Article Text

PDF

HLA-DRB1*04 may be a marker of severity in giant cell arteritis
  1. MIGUEL A GONZALEZ-GAY,
  2. CARLOS GARCIA-PORRUA
  1. Rheumatology Division
  2. Hospital Xeral-Calde
  3. Lugo, Spain
  4. ARC Epidemiology Unit
  5. Manchester University Medical School
  6. Manchester, UK
  1. Dr Miguel A Gonzalez-Gay, Section of Rheumatology, Hospital Xeral-Calde Lugo, c/ Dr Ochoa s/n, 27004 Lugo, Spain.
  1. ALI H HAJEER,
  2. ADELE DABABNEH,
  3. WILLIAM E R OLLIER
  1. Rheumatology Division
  2. Hospital Xeral-Calde
  3. Lugo, Spain
  4. ARC Epidemiology Unit
  5. Manchester University Medical School
  6. Manchester, UK
  1. Dr Miguel A Gonzalez-Gay, Section of Rheumatology, Hospital Xeral-Calde Lugo, c/ Dr Ochoa s/n, 27004 Lugo, Spain.

Statistics from Altmetric.com

Salvarani et al recently studied 39 patients with giant cell arteritis (GCA) and found no association with HLA-DRB1*04.1 In contrast, previous immunogenetic studies did show an association between HLA-DRB1*04 and GCA.2 3Rauzy et al, also, reported a significant increase in DRB1*04 frequency in GCA. HLA-DRB1*04 was present in 20 of their 41 patients with GCA (49%) compared with a prevalence of 20% in the control group.4

Likewise, in a series of 53 patients with GCA from north west Spain, we found a significant increase in DRB1*04 frequency (44%v 26% in the controls).5Although Rauzy did not find a correlation between HLA markers and the initial severity of the vasculitis, there are several similarities between their results and ours. Those authors described a relation between HLA-DRB1*04 and corticosteroid resistance. In our series HLA-DRB1*04 was particularly pronounced in those patients with severe visual complications.5 Both higher corticosteroid requirement and severe ischaemic complications imply a worse outcome of the GCA. This supports the idea put forward by Rauzyet al that HLA-DRB1*04 in GCA may be a genetic marker of severity for this form of vasculitis.

In contrast, although Combe et al described an increased frequency of DRB1*04 in their series of 42 patients with GCA, they did not find a significant relation between markers of disease severity and activity of GCA and HLA-DRB1 genes.6These discrepancies may be related to the different ethnic backgrounds of the groups investigated. The importance of HLA-DRB1*04 in the development of more severe GCA needs to be confirmed by further studies of a greater number of patients. An examination of the importance of other class II and non-class II molecules as markers of severity in GCA is also required.

References

View Abstract

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.